Create a narrative

Recursion Pharmaceuticals Community

NasdaqGS:RXRX Community

1 Narratives written by author
0 Comments on narratives written by author
99 Fair Values set on narratives written by author

Create a narrative

Recursion Pharmaceuticals

AN

AnalystConsensusTarget

Consensus Narrative from 7 Analysts

REC-617 And REC-994 Trials Will Drive Future AI-Driven Drug Discovery Success

Key Takeaways Successful clinical trials and expanded pipeline indicate promising future revenue growth and earnings from potential drug market entries. Strategic partnerships and operational synergies enhance cash flow, efficiencies, and computational capabilities, supporting robust future earnings growth.

US$8.71

FV

50.3% undervalued

64.69%

Revenue growth p.a.

0

0

93

9 days ago